Literature DB >> 17296307

Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery.

Neven Skitarelić1, Miro Morović, Darko Manestar.   

Abstract

BACKGROUND: Perioperative antibiotic prophylaxis has significantly reduced wound infection rates in clean-contaminated head and neck surgical procedures but controversy still remains regarding the optimal antibiotic regime.
OBJECTIVE: To examine the efficacy of different antibiotics in head and neck oncological surgery prophylaxis. PATIENTS AND METHODS: In this prospective, double-blind clinical trial, 189 patients with carcinoma of the upper aerodigestive tract were randomized to receive amoxicillin-clavulanate or cefazolin intravenously up to 1h before surgery and at 8-h intervals for an additional three doses.
RESULTS: An overall wound infection rate of 22% was observed. The infection rate in patients receiving cefazolin was 24% (22/92) vs. 21% (20/97) in those receiving amoxicillin-clavulanate; the difference was not statistically significant. Postoperative overall non-wound infection developed in 12% (22/189) patients; the rate of infection was 9.8% (9/92) in patients receiving cefazolin vs. 13.4% (13/97) in those receiving amoxicillin-clavulanate, without a statistically significant difference between the two groups. Gram-negative bacteria were more often isolated with Pseudomonas aeruginosa as the dominant species. The risk of postoperative infection was more influenced by the type of surgical procedure than by disease stage.
CONCLUSION: In clean-contaminated head and neck oncologic surgery amoxicillin-clavulanate prophylaxis was at least as efficient as cefazolin. However, when taking into account the fact that beta-lactamase containing strains have recently been spreading, amoxicillin-clavulanate should be the logical first choice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296307     DOI: 10.1016/j.jcms.2006.10.006

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  11 in total

Review 1.  [Prophylactic antibiotic use in ENT surgery].

Authors:  C Thorn; A Faber; J D Schultz; K Hörmann; B A Stuck
Journal:  HNO       Date:  2015-02       Impact factor: 1.284

Review 2.  Perioperative Care of Free Flap Patients.

Authors:  Aurora Vincent; Raja Sawhney; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2019-03-08       Impact factor: 2.314

3.  Comparative study of two cefazolin prophylactic protocols in oncologic surgery of the larynx: A randomized trial.

Authors:  Mohammad Taghy; Khorsandi Ashtiani; Mohammad Sadeghi; Babak Saedi; Gilda Givechi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

4.  Antibiotic Use after Free Tissue Reconstruction of Head and Neck Defects: Short Course vs. Long Course.

Authors:  Samir S Khariwala; Bin Le; Brendan H G Pierce; Rachel Isaksson Vogel; Jeffrey G Chipman
Journal:  Surg Infect (Larchmt)       Date:  2015-10-26       Impact factor: 2.150

5.  Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.

Authors:  M Grimm
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

6.  Postoperative abnormal response of C-reactive protein as an indicator for infectious complications after oral oncologic surgery with primary reconstruction.

Authors:  Masaya Akashi; Shungo Furudoi; Kazunobu Hashikawa; Akiko Sakakibara; Takumi Hasegawa; Takashi Shigeta; Tsutomu Minamikawa; Takahide Komori
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-04-02

7.  The impact of a quality management program for patients undergoing head and neck resection with free-flap reconstruction: longitudinal study examining sustainability.

Authors:  Joseph C Dort; Khara M Sauro; Shamir Chandarana; Christiaan Schrag; Jennifer Matthews; Steven Nakoneshny; Vida Manoloto; Tanya Miller; C David McKenzie; Robert D Hart; T Wayne Matthews
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-06-23

8.  Designing and integrating a quality management program for patients undergoing head and neck resection with free-flap reconstruction.

Authors:  Joseph C Dort; Khara M Sauro; Christiaan Schrag; Shamir Chandarana; Jennifer Matthews; Steven Nakoneshny; Vida Manoloto; Tanya Miller; C David McKenzie; Robert D Hart; T Wayne Matthews
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-06-23

9.  Antibiotic Prophylaxis Prescribing Practice in Head and Neck Tumor Resection and Free Flap Reconstruction.

Authors:  John Frederick Daly; Peter Francis Gearing; Nicholas Shi Jie Tang; Anand Ramakrishnan; Kasha Priya Singh
Journal:  Open Forum Infect Dis       Date:  2021-11-24       Impact factor: 3.835

10.  Antimicrobial Prophylaxis in Neonates and Children Undergoing Dental, Maxillo-Facial or Ear-Nose-Throat (ENT) Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Erika Rigotti; Sonia Bianchini; Laura Nicoletti; Sara Monaco; Elena Carrara; Francesca Opri; Roberta Opri; Caterina Caminiti; Daniele Donà; Mario Giuffré; Alessandro Inserra; Laura Lancella; Alessandro Mugelli; Giorgio Piacentini; Nicola Principi; Simonetta Tesoro; Elisabetta Venturini; Annamaria Staiano; Alberto Villani; Enrico Sesenna; Claudio Vicini; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.